| 13 June 2017 | Management of sulfonylurea treated monogenic diabetes in pregnancy: implications of placental Glibenclamide transfer | Shepherd, M; Brook, AJ; Chakera, AJ; et al. |
| 12 October 2017 | Cohort profile for the MASTERMIND study: Using the Clinical Practice Research Datalink (CPRD) to investigate stratification of response to treatment in patients with Type 2 diabetes | Rodgers, LR; Weedon, MN; Henley, WE; et al. |
| 21 July 2017 | Recessively Inherited LRBA Mutations Cause Autoimmunity Presenting as Neonatal Diabetes | Johnson, MB; De Franco, E; Lango Allen, H; et al. |
| 5 August 2017 | Screening for neonatal diabetes at day 5 of life using dried blood spot glucose measurement. | McDonald, TJ; Besser, RE; Perry, M; et al. |
| 16 July 2017 | Neuropsychological impairments in children with KCNJ11 neonatal diabetes | Bowman, P; Hattersley, AT; Knight, BA; et al. |
| 11 September 2017 | Are we missing hypoglycaemia? Elderly patients with insulin-treated diabetes present to primary care frequently with non-specific symptoms associated with hypoglycaemia | Hope, SV; Taylor, PJ; Shields, BM; et al. |
| 20 February 2018 | Fetal Genotype and Maternal Glucose have Independent and Additive Effects on Birth Weight | Hughes, AE; Nodzenski, M; Beaumont, RN; et al. |
| 30 November 2017 | Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank. | Thomas, NJ; Jones, SE; Weedon, MN; et al. |
| 22 December 2017 | Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. | Turcot, V; Lu, Y; Highland, HM; et al. |
| 7 May 2018 | Time trends and geographical variation in prescribing of drugs for diabetes in England 1998-2017 | Curtis, HJ; Dennis, JM; Shields, BM; et al. |
